Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Filamon LTD
Atavistik Bio, Inc
Astellas Pharma Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Alterome Therapeutics, Inc.
Hoffmann-La Roche
Eli Lilly and Company
BeOne Medicines
Bayer
Monte Rosa Therapeutics, Inc
Psyence Australia Pty Ltd
ViroMissile, Inc.
Jazz Pharmaceuticals
Novartis
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Angiex, Inc.
Sapience Therapeutics
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
Daiichi Sankyo
Guerbet
Takeda
Oscotec Inc.
Adela, Inc
Second Life Therapeutics
Acerand Therapeutics Limited
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
MOMA Therapeutics
GlaxoSmithKline
Complement Theory Inc.
Tanabe Pharma America, Inc.
NantCell, Inc.
BicycleTx Limited
AstraZeneca
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Pfizer
Travera Inc
Shanghai Escugen Biotechnology Co., Ltd
Exelixis